These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7669069)

  • 1. In vitro inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced activity by alpha-naphthoflavone and 6-methyl-1,3,8-trichlorodibenzofuran using an aryl hydrocarbon (Ah)-responsive construct.
    Merchant M; Safe S
    Biochem Pharmacol; 1995 Aug; 50(5):663-8. PubMed ID: 7669069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of aryl hydrocarbon receptor antagonists: inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression.
    Merchant M; Morrison V; Santostefano M; Safe S
    Arch Biochem Biophys; 1992 Nov; 298(2):389-94. PubMed ID: 1329656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells.
    Merchant M; Krishnan V; Safe S
    Toxicol Appl Pharmacol; 1993 Jun; 120(2):179-85. PubMed ID: 8390116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies.
    Harris M; Zacharewski T; Astroff B; Safe S
    Mol Pharmacol; 1989 May; 35(5):729-35. PubMed ID: 2542761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of action of alpha-naphthoflavone as an inhibitor of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression.
    Merchant M; Arellano L; Safe S
    Arch Biochem Biophys; 1990 Aug; 281(1):84-9. PubMed ID: 2166479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7.
    Fretland AJ; Safe S; Hankinson O
    Chem Biol Interact; 2004 Nov; 150(2):161-70. PubMed ID: 15535986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonists: characterization of 6-[125I]methyl-8-iodo-1,3-dichlorodibenzofuran-Ah receptor complexes.
    Piskorska-Pliszczynska J; Astroff B; Zacharewski T; Harris M; Rosengren R; Morrison V; Safe L; Safe S
    Arch Biochem Biophys; 1991 Jan; 284(1):193-200. PubMed ID: 1846513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of estrogen-induced activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-7 human breast cancer and other cell lines transfected with vitellogenin A2 gene promoter constructs.
    Nodland KI; Wormke M; Safe S
    Arch Biochem Biophys; 1997 Feb; 338(1):67-72. PubMed ID: 9015389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
    Astroff B; Zacharewski T; Safe S; Arlotto MP; Parkinson A; Thomas P; Levin W
    Mol Pharmacol; 1988 Feb; 33(2):231-6. PubMed ID: 2828916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6 mice.
    Bannister R; Biegel L; Davis D; Astroff B; Safe S
    Toxicology; 1989 Feb; 54(2):139-50. PubMed ID: 2922766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen does not inhibit 2,3,7, 8-tetrachlorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells.
    Hoivik D; Willett K; Wilson C; Safe S
    J Biol Chem; 1997 Nov; 272(48):30270-4. PubMed ID: 9374512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8-trichlorodibenzofuran in the female rat.
    Astroff B; Safe S
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):435-43. PubMed ID: 2847362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3,7,8-Tetrachlorodibenzo-p-dioxin versus 3-methylcholanthrene: comparative studies of Ah receptor binding, transformation, and induction of CYP1A1.
    Riddick DS; Huang Y; Harper PA; Okey AB
    J Biol Chem; 1994 Apr; 269(16):12118-28. PubMed ID: 8163516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
    Wormke M; Castro-Rivera E; Chen I; Safe S
    J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
    Blank JA; Tucker AN; Sweatlock J; Gasiewicz TA; Luster MI
    Mol Pharmacol; 1987 Jul; 32(1):169-72. PubMed ID: 3037301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-naphthoflavone acts as an antagonist of 2,3,7, 8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor.
    Gasiewicz TA; Rucci G
    Mol Pharmacol; 1991 Nov; 40(5):607-12. PubMed ID: 1658599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate.
    Moore M; Narasimhan TR; Steinberg MA; Wang X; Safe S
    Arch Biochem Biophys; 1993 Sep; 305(2):483-8. PubMed ID: 8396892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of o,p'-DDT on the 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible CYP1A1 expression in murine Hepa-1c1c7 cells.
    Jeong HG; Kim JY
    Food Chem Toxicol; 2002 Nov; 40(11):1685-92. PubMed ID: 12176094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation.
    Santostefano M; Merchant M; Arellano L; Morrison V; Denison MS; Safe S
    Mol Pharmacol; 1993 Feb; 43(2):200-6. PubMed ID: 8381508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation.
    Morrow D; Qin C; Smith R; Safe S
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):27-36. PubMed ID: 15026081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.